Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 51662-1638

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride Injection, Solution (NDC 51662-1638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug Interaction Table (51662 1638 Drug Interactions)

A data table titled 'Examples of Drugs Associated with Methemoglobinemia' listing drug classes and corresponding examples, including nitrates/nitrites, local anesthetics, antibiotics, antiparasitics, antimalarials, and anticonvulsants. The table associates specific drugs such as nitric oxide, prilocaine, articaine, benzocaine, dapsone, chloroquine, and phenobarbital with the condition.*

FDA Label Image

Highlights Warning (51662 1638 Highlights Of Prescribing Information Warning)

A boxed warning panel for Bupivacaine Hydrochloride injection solution emphasizing the risk of cardiac arrest associated with its use in obstetrical anesthesia. The warning outlines cases of cardiac arrest with difficult resuscitation or death, advises against the use of the 0.75% concentration for obstetrical anesthesia, and highlights the potential for convulsions due to systemic toxicity.*

FDA Label Image

Manufacturer Label (51662 1638 Mfg Label)

Packaging label for BUPIVACAINE HYDROCHLORIDE injection, solution 5 mg/mL by HF Acquisition Co LLC, DBA HealthFirst. The label shows a perineural injection, solution format with branding and regulatory text. The artwork includes drug information panels and barcode area on the folded carton template.*

FDA Label Image

Structure (51662 1638 Structure)

Chemical structure diagram of Bupivacaine Hydrochloride showing its molecular arrangement including the aromatic ring, amide linkage, and hydrochloride and water components.*

FDA Label Image

Table 1 (51662 1638 Table 1)

A table listing types of nerve blocks and their recommended Bupivacaine Hydrochloride injection concentrations at 0.25% (2.5 mg/mL), 0.5% (5 mg/mL), and 0.75% (7.5 mg/mL). It shows which concentrations correspond to different regional anesthesia techniques such as local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, caudal block, and lumbar epidural block.*

FDA Label Image

Table 2 (51662 1638 Table 2)

A data table titled 'Bupivacaine Hydrochloride Injection Concentration vs. Motor Function' presenting the effects of different concentrations (0.25%, 0.5%, and 0.75%) of bupivacaine hydrochloride injection on motor block characteristics, including suitability and effects on muscle relaxation and anesthesia types.*

FDA Label Image

Table 3 (51662 1638 Table 3)

A data table titled 'Recommended Concentrations and Doses of Bupivacaine Hydrochloride Injection in Adults.' It lists various nerve block types (local infiltration, peripheral nerve block, retrobulbar block, sympathetic block, caudal block, lumbar epidural block) alongside concentration options of bupivacaine hydrochloride injection and corresponding dose ranges in mL and mg for each block type. The table includes dosage notes indicating the degree of motor block expected with each dose.*

FDA Label Image

Pouch Label (51662 1638 2 Pouch Label)

BUPIVACAINE HYDROCHLORIDE injection, solution 0.5%, 5mg/mL, 5mL vial. The label shows the strength as 250mg per 50mL, NDC 51662-1638-2, with lot and expiration details. It includes usage instructions, preservatives, storage conditions, and manufacturer information for HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA.*

FDA Label Image

Case Label (51662 1638 3 Case Label)

BUPIVACAINE HYDROCHLORIDE injection, solution 5 mg/mL vial label from HF Acquisition Co LLC, DBA HealthFirst. The vial contains 250 mg per 50 mL of Bupivacaine HCl. The label includes lot number, expiration date, and storage instructions. It is designated for perineural use and is a case pack of 25 vials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.